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Abstract
The muscleblind (mbl) family of RNA-binding proteins regulates alternative splicing,
determining mRNA transcript composition for various types of tissue, and has been implicated in
myotonic dystrophy. The mbl gene is subject to alternative splicing in Drosophila, leading to
multiple isoforms, and has several paralogs in humans. Mbl proteins vary significantly in length,
although the significance of such diversity and the role of specific isoforms have not been fully
explored.
Using immunofluorescence microscopy and polyclonal serum, we analyzed Mbl protein
expression across adult Drosophila tissues. Mbl was detected in various locations, including the
brain, gonads, muscle, and gut epithelium. Skeletal muscles demonstrated the greatest diversity
in Mbl expression, with other tissues showing more homogenous expression. Mbl was present at
low levels in flight and jump muscles, while other thoracic muscles and abdominal muscles
showed high Mbl levels. Intracellular localization of Mbl was typically nuclear, however in the
nervous system the protein was strongly expressed in the cytoplasm.
During early adult development in the pupa, in various tissues Mbl was initially detected in
discrete nuclear bodies, before it assumed more general nuclear staining.
Our study reveals natural locations that have drastically different levels of Mbl as well as its
intracellular localization.
We conducted tissue specific molecular analysis of mbl transcript alternatively spliced exon
regions using end point and reverse transcriptase qPCR, to determine whether mbl isoforms had
preferential usage in differentiated tissue. Our molecular assays showed that brain tissue had
stronger expression of exon 23 transcript relative to other exons of interest.
Finally, we used fluorescent in situ hybridization probes to characterize expression of
alternatively spliced exon transcripts across differentiation adult drosophila tissue. We found
robust mbl expression in the central nervous system and variable exon presence in visceral and
skeletal muscle tissue. Our findings suggest alternatively spliced mbl exons lead to isoforms with
variable function and expression.
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RT-qPCR (reverse transcription quantitative polymerase chain reaction),
PTM (post translational modification),
OE (over expression),
KD (Knock down),
Mbl (muscleblind protein),
mbl (muscleblind mRNA transcript), isoforms, exon, N-terminal, C-terminal,
FISH (fluorescent in situ hybridization),
MBNL (muscleblind like protein),
MD (Myotonic dystrophy)
NLS (nuclear localization signal)
PBS (phosphate buffered saline)
PBTx (phosphate buffered saline with detergent (Triton X-100))

Introduction
Tissue Diversity:
The development of specialized tissue has increased the survivorship of eukaryotic organisms
throughout evolution. Organizing cells into tissue with distinct morphological and biochemical
features allows an organism to improve the efficiency of various biological processes [TelonisScott et al, 2008]. Differentiating tissue is a highly conserved feature observed in many
eukaryotic organisms. Tissues also diversify down to the cellular and molecular level. There is
research that suggests even tissue that fit under the same category based on cellular features have
molecular variation in gene and protein expression. An example of this is the thoracic muscles of
Drosophila, which have multiple types of muscles and tissue with variation in genetic expression
[Johnston et al, 2020] and the liver tissue of humans [Blake et al, 2020]. Tissue complexity and
diversity is highly conversed in complex eukaryotes and play a crucial role in expanding the
conditions an organism can survivor under. There is still much unknown about the molecular
mechanisms that lead to tissue diversity and cellular complexity.
Structural composition of skeletal muscles:
Skeletal muscle tissue is composed of individual muscle fibers that are organized into bundles,
surrounded by connective tissue sheath (Fig. 1). Muscle fibers are multinucleate membrane
bound cells that vary in diameter and length and contain numerous myofibrils, which arrange
themselves into a packed striated pattern [Luther et al, 2003]. This organization continues down
to the sarcomeres which are the smallest subunit of the contractile apparatus, composed of a
system of structural and regulatory proteins that control the rate at which the sarcomere shortens,
leading to muscular contractions. Myosin heavy chain (MHC) and actin are contractile proteins
that assemble into filaments that stack on each other within the sarcomere [Bechtel et al, 1986].
Troponin and tropomyosin are regulatory proteins that control the rate of contractions by binding
to actin and modulating the actin to myosin interaction. Myosin binding proteins arrange the
structure of the sarcomere leading to the distinct, stable striated structure [Choi et al, 2009].

Figure 1: The composition of human skeletal muscle tissue. Schematic representing the muscle fiber, myofibrils,
and sarcomere of the of the human skeletal muscles. Image credit: [https://openstax.org/books/anatomy-andphysiology/pages/preface]

Muscle types in organisms:
Skeletal muscles of humans and other organisms are not homogenous tissue and can be classified
into multiple subtypes based on their morphology, biochemistry, and performance physiology.
There are multiple ways to characterize the diversity of muscles, including preferred pathway for
energy production (oxidative phosphorylation vs glycolysis), contractile kinetics (slow-twitch vs
fast-twitch), and gene expression (e.g., expression of specific isoforms of muscle genes). For
example, type I fibers are oxidative, able to oxidize fatty acids for a consistent supply of energy,
characterized by being rich in mitochondria and myoglobin and considered to be “slow twitch
fibers”, making them energy efficient and adapted for long periods of continuous contraction and
relaxation [Barany et al, 1967]. In contrast, type II fibers have less myoglobin and mitochondria
but more glycolytic enzymes; these muscles are the “fast twitch” variety, able to perform
glycolysis at much higher rates to produce contractions 3 to 4 times faster than type I fibers with
the tradeoff of being far more susceptible to fatigue [Greising et al, 2012]. Muscle fiber types can
be further categorized into subtypes, based on their molecular composition, and expressed
structural muscle proteins [Scott et al, 2001]. Structural proteins are particularly important for
muscle diversity because their modification has direct impact on muscle contractility and
physical output. A classic example is the diversity of MHC proteins that are produced in a fiberspecific manner [Wells et al, 1996].

Figure 2. Histochemistry reveals various types of skeletal muscle fibers in humans based on differences
in Myosin Heavy Chain. Image credit: [Bloemberg et al, 2012
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035273]

Diversity in the MHC proteins leads to differences in ATPase activity and hydrolysis during
muscle contractions of the muscle fibers. This allows for the identification of myosin heavy
chain variation in muscles fibers by using ATPase staining techniques at different pH levels. At a
pH of 4.6 ATP activity staining shows dark type 1 muscle fibers and lighter type 2 muscles fibers
(Fig.2). The differences in MHC proteins across individual muscle fibers can be clearly
visualized as contractile speed correlates with ATP activity [Morkin et al, 1977] thus muscle
fibers expressing different MHC isoforms demonstrate distinct contractile properties [Eddinger
et al, 1998]. Myosin together with actin, forms contractile filaments in muscle cells to create a
contractile apparatus.
Alternative Splicing and its role in skeletal muscle tissue diversification:
Diversity in proteins such as myosin heavy chain, also known as isoforms, is created from a
process called alternative splicing. Proteins are the building blocks of muscle cells and determine
their function and form. Before proteins can be expressed to create structures in the muscles,
they are first transcribed from DNA into mRNA. The initial mRNA transcript derived from DNA
is known as the pre-mRNA. To be translated into proteins pre-mRNA must go through a process
known as splicing, where the introns, internal non-coding nucleotide sequences, are removed.
This leaves the mature mRNA transcript composed of exons in a single open reading frame of
nucleotides that can be translated into proteins [Lee et al, 2005].
Alternative splicing joins exons together in different arrangements after introns have been
removed. This leads to multiple mature mRNA sequences originating from the same gene. The
varying mRNA sequences are then translated, leading to an array of proteins being derived from

one gene. These different protein variants are called isoforms. Alternative splicing can regulate
the localization of proteins and their enzymatic properties, changes to alternative splicing can
lead to changes in cell proliferation and cellular survival [Dixon et al 2015].
Pre-mRNA splicing is catalyzed by a large ribonucleoprotein (RNP) complex called the
spliceosome. This complex containing specific small non-coding RNAs, and proteins, and
mechanistically carries out the task of intron excision and joining exons together. For that, the
spliceosome must assemble at specific places along pre-mRNA transcript.
Exon and intron boundaries are genomic segments characterized by structural and energetic
properties with a strong link to splicing sites. When transcribed, these junctions are typically
distinguishable by a G-U DNA sequence at the splicing donor and an A-G sequence at the
splicing acceptor, making them recognizable to the spliceosome. [Fincher et al, 2015]. However,
some splicing sites are not readily recognizable by the spliceosome, and they depend on the
activity of additional factors, called splicing regulators or splicing factors. Splicing factors are
proteins or RNPs that are not part of the spliceosome, but they are able to strongly influence the
splicing outcomes [Alberts et al, 2002]. By definition, splicing regulators are critical for
regulating alternative splicing, but their analysis is complicated for multiple reasons. In this
study, we wanted to follow a known splicing factor to demonstrate how it can affect the
diversification of skeletal muscle tissue.
Drosophila model to study muscle differentiation and diversity:
The fruit fly Drosophila melanogaster makes a useful model organism for studies in genetics and
developmental biology [Mohr et al, 2019]. Researchers have been able to uncover some of the
mechanisms behind complex mutations and diseases on a multicellular level. Studies on the
Drosophila germline have been able to identify mechanisms that prevent the accumulation of
mitochondrial deleterious deletions, which provides insight into mitochondrial based diseases in
humans [Palozzi et al, 2018]. It has also been shown that the perturbation of genes using RNAi
to replicate diseases can be used to design treatments for human patients. [Bangi et al, 2019]
implemented a cancer treatment by using RNAi to perturbate nine genes, causing tumors that
replicate the diseases, displaying how Drosophila can effectively be used as a model to study
human diseases.

Figure 3. Schematic showing the variation in striated muscle tissue of the Drosophila Thorax. Image Credit:
[Poovathumkadavil et al 2020 https://www.mdpi.com/2073-4409/9/6/1543/htm]

Flies use the same type of striated muscle type for their skeletal musculature as mammals (Fig.3)
[Nikonova et al, 2020]. There are a variety of muscle tissue types in the body of the fruit fly that
are different in morphology and functionality [Dobi et al, 2015]. The largest muscles in the fly
body are the indirect flight muscles (IFMs), which specialize in ultra-fast contractions and
belong to the fibrillar type (Fig.3). However, most Drosophila muscles belong to so-called
tubular type. That includes fly’s second largest muscle, the TDT (Tergal Depressor of the
Trochanter), also called the jump muscle because it is solely responsible for jumping in flies
(Fig.3). Among the tubular muscles of the thorax, there are other, smaller muscles, such as
subalar muscle (controls the position of the wing blade) that look quite distinct from IFMs and
TDTs. However, IFM and TDT muscles have an advantage in that they can be tested
functionally with the flight and jump test, respectively [Chechenova et al, 2017]. Owing to this
convenience, IFMs and TDTs have been a model for studying the mechanisms of muscle fiber
diversity [Oas et al., 2014; Bryantsev et al., 2012].

Muscleblind:
The subject of this study, the gene muscleblind, derives its name from the pivotal role it plays in
the development of muscles and photoreceptors in Drosophila; in many cases mbl genetic
mutants are lethal. [Machuca-Tzili,et al, 2006]. The evidence that Mbl protein is a splicing
regulator comes from the fact that it has two zinc-finger domains, capable of binding RNA
molecules [Begemann al,1997] and that mbl mutants have abnormal mRNA splicing patterns
[Vincente-Crespo et al, 2008]. Reverse-transcription PCR (RT-PCR) has shown alterations in
MHC splicing events when the expression of mbl is decreased in the Drosophila pupa
[Fernandez- Costa et al, 2013]. During Drosophila development, muscles differentiate and
develop different morphological features based on their function. mbl expression is present
during this stage of muscle differentiation. Interrupting the expression of mbl in larvae leads to
embryonic lethality and alterations in muscle morphology, suggesting mbl contributes to
regulating alternative splicing of Drosophila muscles genes and showcasing that mbl participates
in alternative splicing [Begemann et al, 1997]. The analysis of mbl function is complicated
because the mbl gene itself is a subject of alternative splicing regulation and generates multiple
mRNA and protein isoforms (Vicente et al, 2007). More insight on the importance of mbl for
proper functioning comes from other animal models as well as human disease myotonic
dystrophy.
While Drosophila has only one mbl gene, mammals have five homologous genes called MBNL
(Muscleblind-like) whose expression has been detected in the neurons, blood cells and organs
during embryonic development of mice [Goers et al, 2008]. Most of the information is available
for MBNL1 gene, which shares >50% homology with Drosophila mbl [Oddo et al, 2015].
MBNL1 knockout mice display muscular abnormalities specifically along the lining of the
abdominal region, as well as atypical neural morphology [Poulos et al, 2013]. MBNL1 is
expressed in tissues that also express structural muscle proteins cardiac troponin (cTnT) and
skeletal muscular troponin (TnnT3) [Pascual, 2006].
Myotonic Dystrophy:
Strong interest is drawn to the MBNL1 gene because of its involvement in human pathology,
such as Myotonic Dystrophy. This hereditary disease (type 1 and 2 recognized) causes
malfunctions in the cells of the neuromuscular, cardiovascular and skeletal muscle systems in
those afflicted. The name of this disease is derived from the symptoms that are characterized by
myotonia, delayed muscle relaxation and dystrophy, wasting of tissue [Picchio et al, 2018].
These malfunctions lead to severe muscle weakness, heart complications, and rapid degeneration
of muscle tissue.
The currently accepted mechanism of MD postulates that MBNL1 becomes trapped irreversibly
bound to CUG or CCUG repeats that can are present in the non-coding regions of some mRNAs
(Fig. 4) [Cho et al, 2007]. These CUG expansions sequester a large amount of MBNL in
insoluble intranuclear foci. Due to depletion of available MBNL1 in the nucleus, the alternative
splicing of multiple genes becomes affected as a result. This eventually results in multiple
irregular splicing events occurring across various genes [Lee et al, 2009]. For example, [Philips
et al, 1998] used RT-PCR on the cTNT mRNA of myotonic dystrophy 1 patients and found that
the proportion of the exon that was alternatively spliced increased with nucleotide repeat length,
heavily suggesting that the sequester of MBNL1 leads to mis-splicing events in MD patients.

Other investigations have found that the overexpression of MBNL1 in mice reduces myotonia
and RNA mis-splicing events in the TnnT3 transcripts in the transgenic mice with MBNL1
knockdown, highlighting how crucial the role of MBNL1 is in regulating splicing events of
skeletal muscle proteins [Cerro-Herreros et al, 2018].

Figure 4. Molecular Mechanism of myotonic dystrophy. The schematic
representation of the molecular mechanism of myotonic dystrophy.
Expression of expanded CTG nucleotide repeats in transcripts from
DMPK and/or traps MBNL protein. Image credit: [Chau et al, 2014
American Association for Anatomy
https://anatomypubs.onlinelibrary.wiley.com/doi/full/10.1002/dvdy.24240]

Materials and Methods:
Fly stock and storage
Fly stocks were obtained from the Bloomington Drosophila stock Center (unless otherwise
indicated) and maintained in bottles and vails containing standard Jazz formula fly food
(ThermoFisher). Drosophila w1118 genotype was used for immunofluorescent microscopy and
molecular analysis of muscleblind (mbl). This line was kept at room temperature in the lab.
Genetic crosses with mbl knockdown in muscles were attained using an RNAi construct with a
Mef2TS (temperature sensitive) genetic driver. For genotypes with mbl knockdown in the central
nervous system, Elav-Gal4 driver flies were crossed with mbl KK (105486) (Vienna Drosophila
stock center) inverted repeat (RNAi) flies and raised at 25C. Fly lines with mbl isoforms
overexpression (gift from Dr. Ruben Artero, University of Valencia, Spain) had upregulation of
Mbl isoform crossed with Mef2-Gal4 genetic driver line. Mbl overexpression crosses were raised
at 25C.

Cryosectioning
Flies were sorted by gender, male and female adult eclosed flies were distinguished by the
pigmentation of their lower abdominal and the presence of an oviposition at the bottom of the
abdominal region. Uneclosed adults (pharate adults) were sex characterized by sex combs.
Adults were anesthetized by transferring them from their container to a CO2 pad. Flies were then
immobilized in a high viscosity glycerol and resins solution (Tissue-Tek). The wings and legs
were amputated using a needle while flies were submerged in Tissue-Tek. Double sided sticky
tape was placed onto a metal spatula, a strip of paper designed to label samples was stuck to the
bottom of the tape. A small portion of Tissue-Tek was spread onto the tape. Amputated flies
were placed dorsal side down onto the tape then covered with more Tissue-Tek. After being fully
submerged in Tissue-Tek flies were repositioned to ensure even sections. Pharate adults were not
amputated, a small incision was made in the pupa casing to allow Tissue Tek to surround the fly
after they were placed onto the spatula dorsal side down. After samples were fully submerged in
Tissue-Tek the spatula was submerged in liquid nitrogen briefly to freeze the flies. The tape,
label and frozen sample were removed from the spatula. If frozen blocks were not immediately
sectioned, they were stored in a 15ml centrifuge tube and placed in a box at -80C. To section,
the cryotome was set to -21C. Tissue Tek was placed onto a metal knob, which was then placed
into the cryotome. Samples were mounted onto the knob as the Tissue-Tek froze. The tape and
label were removed, and samples were placed parallel to the sectioning blade. 10-um thick
sections were collected onto a glass slide and allowed to air dry for 15 minutes before being
placed in a cold box for storage at -4C.
Immunofluorescence
The following serums were used as primary antibodies for cryosection staining: polyclonal sheep
anti-Mbl serum used as Mbl antibody (1:5,000) concentration [Houseley et al, 2005] (where we
got the mbl from). Anti-Mef2 rabbit serum (gift from Dr. Richard Cripps, University of San
Diego, CA) was applied at a concentration of (1:500) to identify Mef2 protein, a transcription
regulator used as a marker to identify differentiating muscles cells of larva, pupa, and young
adult (pharate) flies [Elgar et al, 2008]. Cy3-labeled donkey anti-sheep and Alexa647-labeled
goat anti-rabbit immunoglobulins (Jackson ImmunoResearch) were used at a 1:400 dilution as
secondary antibodies to visualize Mbl and Mef2 presence.

Slide staining protocol and microscopy
Slides were fixed before staining by incubating in 3.7% formaldehyde diluted in 1x phosphate
buffer saline for 10mins. Then slides were rinsed in phosphate buffer saline with 0.1% Triton X100 twice for 3 mins. Slides were then permeabilized by incubating in 1% Triton X diluted with
phosphate buffer saline (PBTx) for 30mins on a rocker platform set to 30 rpm. Afterwards, slides
were rinsed twice with PBTx. Excess PBTx was drained from the slides then 90ul of primary
antibody solution containing sheep anti-Mbl (1:5,000) and rabbit anti-Mef2 (1:500) were
applied. Primary antibodies were diluted with 1x PBTx. A cover slip was then placed on the
slides which were incubated in a petri dish overnight at room temperature. Post incubation, slides
were rinsed for 5mins in PBS to removed coverslips. Secondary antibody solutions diluted with
PBS contained donkey Cy3-labeled anti-sheep (1:400) and Alexa647-labled goat anti-rabbit
immunoglobulins as well as well as DNA dye DAPI (1:500, Sigma) and iFluor488-labeled
phalloidin (1:1,000, Abcam) to counterstain polymerized actin. Ninety microliters of the

secondary staining solution were applied to slides and covered with a fresh coverslip and
incubated in a humid chamber for 1hr at room temperature. After the incubation, the slides were
immersed in PBTx to remove the coverslips. Slides were mounted by applying 70ul of the
mounting Mowiol medium (0.12 g/ml Mowiol 4-88 (Sigma), 0.3 g/ml glycerol, 120 mM Tris pH
8) then protected with fresh coverslips. Slides were allowed to dry for 1min before being stored
at -4C. Images were taken using digital stitching of Zeiss LSM900 confocal microscope.
RNA extraction and cDNA synthesis
Female flies were preferred for molecular analysis. Ten to fifteen flies submerged in Tissue-Tek,
following the thorax, head, legs, and abdominals were separated using a fresh sterile syringe
needle, body parts were placed into separate Eppendorf tubes and washed three times in 1ml of
1X Thermofisher phosphate saline buffer (PBS). For micro-sampling from the brain,
micromanipulator-controlled glass capillary needle was used to scrape the tissue from fresh
20um cryosections of fly heads (described in [Bryantsev et al., 2019]). The scraped material was
then transferred to the RLT buffer from the extraction kit as described below. The RNease mini
extraction kit (QIAGEN) was used to process samples. To lyse cells 50ul of RLT buffer was
added to Eppendorf tube containing tissue samples. An electric grinder was used at full speed for
no less than 4 minutes to homogenize the samples. Then 300ul of RLT buffer was added to the
sample, homogenized sample was transferred to RNA kit Qia Shredder and centrifuged at 1600
rpm for 2minutes. 350ul of 70% molecular grade ethanol was added to samples and aspirated 10
times to mix. The 700ul mixture was transferred to an RNease column and centrifuged at 8500
rcf for 30 seconds. The flow through was discarded leaving the supernatant in the column. The
column was centrifuged again after adding 350ul of RW1 buffer. Afterwards 10ul of DNase and
70ul of RDD buffer were added, the column was left to incubate in a sterile fume hood for 1
hour. The column was then centrifuged and the flow through was discarded. Column was then
centrifuged with 350ul of RW1 buffer, then 500ul RPE buffer for 30 seconds and 2 minutes at
8500rcf respectively. Finally, 30ul of RNase free water was pipetted into the column and
centrifuged at 10,000 rpm for 1 minute. The RNA sample was taken to a ThermoFisher nanodrop
to test purity and concentration of RNA extract. RNA extract samples were stored at -80C in
microcentrifuge tubes. To synthesis cDNA the following reagents were added to a PCR tube: 1ul
of 50mM random primers, 1ul of 10uM dNTPs and 12ul of extracted RNA solution. Then
samples were run in thermocycler for 1 cycle of 65C for 1 min and 4C for 1min. After 1 cycle
the following reagents were added: 4ul of 5X SS IV buffer, 1ul of 100mM DTT and 1ul of the
SS IV enzyme. Samples placed in thermocycler for one cycle of 23C for 10mins, 55C for 10mins
and 80C for 10mins. Synthesized cDNA was diluted 5 times with RNase free molecular grade
water and stored at -80C.
End-point PCR and Gel electrophoresis
Diluted cDNA was used as the template for mbl exon amplification. Primers were selected by
taking short exon sequences with alternatively spliced variants, as presented by flybase.org RNA
annotations. We used six forward and reverse primer combinations targeting exons, 5, 10, 15,
17, 20 and 23. For PCR reaction 1ul of the diluted cDNA from a given tissue was mixed with the
following: 20ul of dH20, 2.5ul of 10x Buffer (advantage), 0.5ul 10mM of dNTPS, 0.5ul of 50x
Advantage DNA polymerase mix (Takara) and 0.5ul of 100 uM reverse and forward primers for
the individual exon target. The mix was placed in a thermocycler for 35 cycles (95C 1min, 95C
30secs, 72C 1min). Amplicon samples were mixed with 6X SDS purple loading dye (0.03%

bromophenol blue, 0.03% xylene cyanol FF, 60% glycerol, 1% SDS, 100 mM EDTA) at a 1:5
volume ratio. Final PCR products and 100bp ladder were loaded into separate well of a 2%
agarose gel. Gels were placed in a cast and submerged in 1x TAE (Tris-Acetate-EDTA) buffer.
The BioRad electrophoresis power supply was set at 200V with 500amps for 15mins. The
resulting gel was imaged using Chemidoc imaging system (BioRad). Gels were analyzed and
adjusted in color for consistency using BioRad Image lab 6.1 software.
qPCR
Primers for qPCR were selected based on Flybase.org annotation of the mbl genome. We used
primers that target 5 different exon regions: exon 5, 10, 15, 20 and 23. Preliminary QPCR
analysis using exon 5, which is present in all isoforms was done to calculate the dilution factor
for the cDNA from each tissue sample to keep concentrations relative. Head cDNA samples
were most concentrated based on endpoint PCR results and Nano drop quantification. Therefore,
head samples were used as a comparative measurement for brain and other tissue samples. Head
cDNA was diluted in a range from 1:30 to 1:920 dilution factor with each dilution factor being
two-fold of the previous, brain was tested at a dilution range of 1:4 to 1:64. A range of diluted
concentrations was then calculated from the preliminary data. New cDNA samples dilution
factors were selected at a shorter range of concentrations 1:10, 1:20, 1:40, 1:80 and 1:160 for
head. Brain samples were used at dilution factors of 1:4, 1:8, 1:16, 1:32 and 1:64.
For RT-QPCR reactions of both preliminary and final results a master mix was made
containing: 1ul per reaction of both forward and reverse primer for the exon being amplified and
7.5ul of Thermofisher SYBR green dye per sample. A sterile 96 well plate was used to house
PCR reactions. Then 6.5ul of cDNA at a given concentration was pipetted into the wells. Each
reaction had an identical back up well. Also, two wells filled with 6.5ul of molecular grade dH20
were to be used as controls. Following 8.5ul of master mix was added to each well. The 96 well
plate was centrifuged then ran in Bio-Rad RT-QPCR thermocycler for 35 cycles. Quantification
of amplicons were done using Bio-Rad CFX Maestro 2.2 (5.2.008.0222) by comparing the mean
quantitation value (Cq) of each well. Each reaction was duplicated, we took the average Cq score
of both reactions as a representation of the expression of the target amplicon.

Fluorescence In Situ Hybridization Staining (FISH)
Stellaris RNA FISH probes were designed according to the manufacturer’s instructions using
Stellaris Probe Designer (Biosearch Technologies). Each probe contains a mixture of 24-48
individual Quasar® 570-labeled RNA oligos complementary to the four mbl terminating exons
(see Fig. 12A). For FISH staining, slides were fixed by placing slides 3.7% formaldehyde diluted
in 10x PBS for 10 mins. Slides were then placed in a petri dish and rinsed 3x with nuclease free
molecular grade PBS for 2mins each time. After rinsing slides were placed in a 50ul centrifuge
tube of 70% ethanol for 1 hour at room temperature. Slides were then washed by pipetting wash
buffer A onto each slide for 5mins. We pipetted 200ul of hybridization mixture (20ul of
formamide, 2ul of 12.5 uM mbl exon probe and 180ul of hybridization buffer) onto each slide,
covered the slides with a coverslip and let them incubate at room temperature overnight. Slides
were washed with wash buffer A for 30mins at 37C and the coverslips were removed. We then
pipetted 200ul of 1:1000 concentration DAPI diluted in wash buffer A onto slides, placed a fresh
coverslip and let slides incubate for 30mins at 37C. Then coverslips were removed by incubating

slides in wash buffer B for 5mins. Finally, 90ul of mounting media was pipetted onto the slides.
Slides were stored at -4C in a cardboard box before images were taken at 63x magnification with
AxioImager fluorescence microscope (Zeiss).
Flight Test
To assess flight ability, we used no less than 50 flies per genotype. Flies of each genotype were
released one-by-one from a vial into a ~150L plastic chamber and their flight trajectory and
landing site were traced. The boundary marks inside the chamber’s walls indicated whether flies
flew up (to the top of the chamber), down (gradual decent to the bottom of the chamber, high
(flew up but not able to land on the roof of the chamber) and null (falling directly to the floor of
the chamber with no attempt to fly).
Embryonic lethality assessment
Genotype crosses were made in bottles containing jazz fly food and raised at 25C. Once bottles
showed offspring at the larval stage and early pupa stage, roughly 6 to 7 days after flies were
crossed, the adults were removed from the bottle. Each day as adults eclose, bottles were cleared
twice a day, once in the late morning and again in the late afternoon. After 5 to 6 days the
remaining pupa cases were tallied. Dark pupae that did not eclose were counted as lethal cases,
empty pupal cases that show successful eclosion were counted as live cases. The final score was
calculated as percentage of lethal cases by total number of pupae analyzed.

Results:
Complexity of the mbl genetic locus
According to the current Drosophila genome assembly (r6.45, Flybase.org), the muscleblind
genetic locus produces 19 annotated RNA transcripts via a combination of alternative splicing
and alternative transcription termination (Fig. 5A). We have dismissed 5 transcript isoforms
(RV, RW, RX, RZ and RY) as being intermediates of nonsense-mediated mRNA decay, because
they are lacking the extended 3’ UTR. The rest of the transcripts code for annotated proteins that
substantially differ in size (Table 1). For example, the smallest Mbl isoform (isoforms A, 22.7
kDa) is ~ 5 times smaller than the longest isoform (isoform P, 101.3 kDa). All Mbl isoforms can
be generally grouped by the terminating exons of their corresponding RNA transcripts. Exons 10
and 15 belong to single isoforms (isoforms A and B, respectively), while Exons 20 and 23 are
associated with multiple isoforms (Fig. 5A). Typically, most Mbl isoforms ending with the same
exon have identical C-termini, with the exception of isoforms D and U that terminate with exon
23 but do not receive the coding sequence from it due to an earlier stop codon in an upstream
exon. In contrast to the diverse C-termini, all Mbl isoforms share the same N-terminus,
composed of 121 amino acids and coding for two Zinc-finger, CCCH-type motifs (Znf, 18-45
and 52-79 aa). Such Zfn motifs can potentially bind nucleic acids and other substrates [Laity et
al, 2001]. In addition to the Zfns, the long Mbl isoforms contain intrinsically disordered regions
(Fig. 5B). The presence of multiple isoforms suggests that Mbl is a protein of high
diversification, potentially fulfilling multiple roles within the cell or across different tissues
[Pascual et al, 2008]. The variable C-termini may be required to regulate substrate binding,
realized by the N-terminus, or intracellular trafficking of the Mbl protein.
Table 1 Molecular properties of the main classes of Mbl protein isoforms.
Mbl protein
MW
Length
Znf
NLS
Terminating exon
isoforms
(kDa)
(aa)
Mbl PA
22.7
203
present
no
Exon 10
Mbl PB
32.3
297
present
no
Exon 15
Mbl PD
26.9
243
present
no
Exon 20
Mbl_PP
71.9
667
present
bipartite
Exon 20
Mbl PN
58.2
535
present
no
Exon 20
Mbl PO
63.4
583
present
no
Exon 20
Mbl PU
42.2
391
present
bipartite
Exon 20
Mbl_PR
101.3
956
present
monopartite
Exon 23
Mbl PJ
82.5
789
present
monopartite
Exon 23
Mbl PK
84.2
803
present
monopartite
Exon 23
Mbl PS
97.6
925
present
monopartite
Exon 23
Mbl PM
91.0
873
present
mono- & bipartite
Exon 23
Mbl PH
99.5
951
present
mono- & bipartite
Exon 23
Mbl PT
99.2
939
present
monopartite
Exon 23

Differential expression of the Mbl protein in adult tissues
Adult tissues offer the highest complexity in Drosophila, especially in the organization of the
nervous and muscle systems that contain structures that are not present in other Drosophila
lifeforms (Fig. 6). To explore Mbl expression in adults, we used a polyclonal anti-Mbl serum to
detect all Mbl isoforms. We detected Mbl at multiple locations within the fly body, most notably
in the gut epithelium, central nervous system, eye, gonads, and various somatic muscles (Figs. 79).
Simple tubular muscles of the abdominal wall, legs and head strongly express the Mbl protein
(Fig. 7A). The most diverse Mbl expression was detected in the thoracic muscles that are
represented by highly specialized groups, including the Indirect Flight Muscles (IFM), the Tergal
Depressor of the Trochanter (TDT, or jump muscle), and an array of Direct Flight Muscles
(DFM) (Fig 6B). Based on immunofluorescence data, IFM and TDT have little to none of Mbl
expression, while DFM demonstrate a very strong Mbl expression (Fig. 7B). Within the TDT, a
stronger immunofluorescence signal was detected in the small cells [Jaramillo et al, 2009] than
the large cells (not shown). In all Mbl-expressing muscles the protein was nuclear.
The nervous system, represented by the ventral cord, brain, and eyes (Fig. 6C) has the strongest
expression of Mbl among all tissues. In the Drosophila brain there are two morphologically
distinct population of neurons, large cells and small cells [Hanesch et al, 1989]. The vast
majority of cell bodies in the Drosophila are neurons [Awakasi et al, 2008] We detected Mbl
primarily in the large neurons. Unlike muscles, the immunofluorescence signal in neurons was
detected mainly in the cytoplasm (Fig. 8A). Similarly intracellular distribution of Mbl was found
in the neurons of the ventral cord. Although they are also neurons the photoreceptors in the eye
display strong nuclear localization (Fig. 8B).
Other tissues besides nervous and muscle tissues also displayed notable expression of Mbl. In
testis, a strong immunofluorescence signal was detected in developing spermatocytes as large
foci (bodies) within the dilated nucleus with partly condensed chromosomes (Fig. 9A). In
contrast, no specific signal was detected in ovaries. Gut epithelium had large, polyploid epithelial
cells (enterocytes) expressing nuclear Mbl, while small, diploid intestinal stem cells did not
express Mbl (Fig. 9B). We also detected Mbl expression in the nuclei of small visceral muscles
surrounding the gut loops and other internal ducts (not shown).
In summary, Mbl protein is widely present across adult tissues, but in some locations, it is
subject to expression restrictions. Within cells, Mbl localization is also regulated as the protein is
present at various places, including the cytoplasm, nucleus, or nuclear foci/bodies.
Developmental dynamics of Mbl expression
Next, we wanted to investigate developmental dynamics of the Mbl expression in the tissues
with selective Mbl presence.
The central nervous system of the 3rd instar larva consists of the brain and ventral cord (Fig. 6B).
Mbl is robustly expressed only in a smaller set of neurons (Fig. 8C). Interestingly, Mbl in the
larval neurons is partially nuclear, which is in contrast to the predominantly cytoplasmic Mbl in
adult neurons (Figs 8A vs 8C).
In 3rd instar larvae, all somatic muscles, including body wall muscles and visceral muscles,
robustly express Mbl in the nucleus (Fig. 10A). We followed Mbl expression during one case of
larval-to-adult muscle transformation. In most instances, muscles of adults are formed de novo in
the pupa from single-nucleate progenitors [Fernandes et al, 1991]. One exception to that rule is
the group of IFMs that are formed on the basis of the pre-existing template of a larval wall

muscle (Fig. 10C). In the early pupa at 16 h after puparium formation (apf), the larval IFM
precursors are visible because of their large, round polyploid nuclei, which are surrounded by
numerous small diploid nuclei of myoblasts (Fig. 10B). At this stage, Mbl in the larval
precursors is concentrating in a single, compact body within the nucleus (Fig. 10B). This Mblcontaining nuclear body is known from a previous study as the B-body, because it expresses the
protein Bruno [Oas, et al 2014]. At 24 h apf, the nuclei of larval template muscles become
incorporated into nascent IFM fibers, but still can be identified by their size and round shape. At
this stage, Mbl is no longer discernable in B-body or anywhere else in IFMs (Fig. 10C).
Similar observations were made in the gut epithelium. During metamorphosis, a newly made
epithelial layer envelopes the older larval gastrointestinal tube, which is slated for subsequent
degeneration and ingestion [Jiang et al, 2009]. We found that smaller, peripherally located
epithelial cells express Mbl in compact, brightly stained nuclear bodies (Fig. 10D). Since no
Bruno expression is expected in these cells, we dubbed these structures as “M-bodies” to distinct
them from B-bodies. The older, larval cells that concentrated interiorly also contained M-bodies
albeit at a lower intensity.
Collectively, our observations strongly suggest that intracellular localization of the Mbl protein
is under dynamic regulation and responds to the stages of the developmental program. The
accumulation of Mbl in nuclear bodies may reflect transcriptionally inert cells that are either at
the beginning or terminating stages of their developmental programs.
Analysis of mbl transcript diversity and expression
The immunofluorescence analysis performed with polyclonal anti-Mbl serum is non-informative
about isoform-specific expression. The anti-Mbl serum repeatedly failed to produce specific
bands in a Western blot of Drosophila lysates, making this way of protein isoform analysis
unusable (not shown). Therefore, we turned to molecular biology methods to assess Mbl
diversity in adult tissues at the transcript level.
We first assessed the diversity of mbl transcripts by end-point RT-PCR and a set of primers
amplifying alternatively spliced regions of the mbl locus (Fig. 11A). Samples prepared from the
thorax and the head produced multiple products of predicted sizes along with a few non-expected
DNA bands (Fig. 11B). Notably, the overall isoform repertoire was very similar between these
samples. Both head and thorax consist of tissues that, according to our immunofluorescence
analysis, demonstrate variable expression of the Mbl protein. To get a more homogeneous
sample, we sampled the brain tissue (excluding the eyes and other tissues of the head) using the
microscraping technique [Oas et al. 2014]. Even with this accurate sampling technique, the
repertoire of mbl isoforms closely resembled those found in the whole head or thorax (Fig.
11B).
We used real-time RT-qPCR to quantify mbl isoform usage in the brain sample. Expression of
each terminal mbl exon was normalized by the expression of the commonly included exon 5
(Fig. 12A). The RT-qPCR data confirmed that Drosophila brain co-expresses multiple mbl
isoforms. Further, we found that terminal exon 23 was the most abundant in the brain tissue.
To resolve isoform expression at the cellular level, we applied fluorescence in situ hybridization
(FISH) with a series of probes targeting the terminal mbl exons. We were particularly interested
in investigating isoform usage in those tissues that demonstrated cytoplasmic (brain) versus
strictly nuclear (eye) localization of the Mbl protein (Fig. 13A). Mbl-expressing cells were
detected by visualizing fluorescent puncta concentrating around transcriptional sites inside the
nucleus or scattered across the cytoplasm (Fig. 12B). In the brain, we detected expression of all

terminal exons (Fig. 13B), with exons 10 and 15 being expressed in a wide range of cells, exon
23 being highly expressed albeit in a subset of neurons, and exon 20 being most weakly
expressed. In the eye, exons 10 and 15 had the strongest expression, while exons 20 and 23 had
the weakest expression (Fig. 13B). In other adult tissues, exon 15 had the widest distribution
across neuronal and muscle tissues (Fig. 13C).
Collectively, our data demonstrate that multiple mbl transcript isoforms are co-expressed within
the same tissues and even the same cells. The presence of unexpected RT-PCR amplification
products also suggests that the annotation of the mbl transcripts is not complete as there still
might be novel isoforms present. However, this cannot be confirmed until these unexpected
amplicons are extracted and sequenced.
Nuclear localization signal
Since FISH data revealed a differential usage of terminal exons in the tissues that express
cytoplasmic and nuclear Mbl protein (brain and eye, respectively), we conducted an in silico
search across all Mbl isoforms for nuclear localization signal(s) (NLS). Using the NLS Mapper
(http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi), we identified two putative
NLS sequences with high probability scores (Fig. 12C). Applying reverse transcription, we
mapped these sequences to terminating exons 15 and 20. Notably, these exons have the lowest
abundance in the brain (Fig. 12B) and the strongest abundance in the eye (Fig. 13B). We
conclude that isoform selection may regulate intracellular localization of the Mbl protein.
Testing for functional importance of Mbl isoforms
To probe into the functional significance of Mbl isoforms, we overexpressed isoforms A and B
in all muscles, using a muscle-specific driver (Mef2-Gal4). Flies overexpressing Mbl-A eclosed
normally and were active, but flies overexpressing Mbl-B had mild lethality due to inability to
eclose (Fig. 14A). We also tested the effect of Mbl-A and Mbl-B overexpression on the flight
muscles that normally do not express Mbl (IFM, Fig. 7A). IFM functionality was tested by the
flight test with young adults. Overexpression of isoforms A and B flies completely impaired the
function of IFMs and resulted in non-flying phenotype (Fig. 14B).
Alternatively, we carried out tissue-specific knockdowns of the mbl gene, using the RNAi
construct that targets all mbl transcripts. Reduction of mbl expression in muscles did not prevent
normal development until pharate adult stage but rendered new flies unable to eclose (Fig. 14C).
In contrast, reducing Mbl in neurons using Elav-Gal4 driver did not affect fly development and
resulted in active adults.
We conclude that Mbl in muscles is essential, while in neurons it is dispensable. Interestingly,
the differences in Mbl knockdown effects reflect the differences that were found in the
intracellular localization of Mbl in muscles (nuclear) and neurons (cytoplasmic).

Figure 5. Complexity of the Mbl genomic locus. (A) Schematic illustrating summary of alternative splicing events
across the mbl RNA transcript. Mbl mRNA transcript is differentially spliced at particular exon regions leading to
multiple isoforms. Grey regions indicate introns, beige areas indicate exons coding regions. Exon 5 is present in all
isoforms while exon 10, 15, 20 and 23 are absent in some isoforms. Orange blocks indicate the relative position of
nucleotides coding for two Zinc-fingers motifs (Zfns). (B) Intrinsically disordered regions of the long Mbl isoforms
as predicted by the DISOPRED 3 (http://bioinf.cs.ucl.ac.uk/psipred/). Plotted values close to 1 at the Y axis
correspond to disordered protein segment. Relative position of Zfn motifs highlighted by orange stripes.

Figure 6. Schematic indicating tissue analyzed for mbl expression. (A) Schematic showing developmental
stages of drosophila melanogaster from fertilization to birth. https://www.creative-diagnostics.com/Drosophila.htm
(B) The diagram illustrates regions of interest in the 3rd instar larval body that have differentiated into specialized
tissue and therefore contain transcripts subject to alternative splicing. (C) Mature 24-hour pharate adults with fully
differentiated tissue, the diagram showcases tissue regions where mbl expression was characterized.

Figure 7. Mbl shows nuclear localization in muscle tissue and differential expression in specialized muscles of
the thorax. (A) Immunofluorescence staining of 1-day old (24hr) W1118 pharate adult drosophila abdominal wall,
head, thorax and legs show mbl is ubiquitously expressed across muscle tissue in organized nuclear domains. White
measure bars represent 5um. (B) Muscles of the thorax show great diversity in mbl expression. Direct flight muscles
(DFM) have clear mbl expression much like other muscle types while indirect flight muscles (IFM) and jump
muscles (TDT) are nearly absent of mbl expression. White measure bars represent 10um.

Figure 8. Mbl shows both cytoplasmic and nuclear localization in the central nervous system. (A)
Immunofluorescence analysis of mbl in the entire head and brain of 1 day old (24) pharate adults using fluorescence
microscopy. Neural cells show significant cytoplasmic expression while other tissue types have nuclear expression.
Left panels are higher magnification of nervous cells. White arrows indicate cytoplasmic expression of mbl in a
nerve cell. White arrows on larger magnification of the head indicates eye (E) the brain (B) and optic region (O).
(B) Photoreceptors of the eye reveal both nuclear and cytoplasmic expression of mbl. Upper most white arrow
points to cytoplasmic expression while lower white arrow points to nuclear expression. (C) DNA and Mbl staining
larval brain shows Mbl expressed in nuclear domains.

Figure 9. Mbl shows strong expression in testis and midgut. (A) Immunofluorescence signal in adult 1-day old
w1118 flies shows differential expression in ovaries when compared to testis of adult flies. Testis have specific mbl
staining with distinct protein accumulation. Left most panels are higher magnification of testis cells. Ovaries show
non-specific fluorescence signal. (B) Mbl immunofluorescence in a tangential section through the midgut
epithelium. Nuclear expression is evident in large, polyploid nuclei of the differentiated enterocytes, while smaller,
diploid nuclei of the intestinal stem cells are void of signal.

Figure 11. The diversity of mbl isoforms in adult Drosophila tissue revealed by end-point RT-PCR. (A)
Schematic representation of amplicons (C1– C6) designed for end-point RT-PCR analysis of mbl transcripts. Boxes
depict exons, lines—introns. Coding frame is colored in light green, non-coding sequences are grey. Primer binding
is indicated by short black lines. mbl isoforms predicted to amplify by each amplicon are listed. Drawings are not to
scale. (B) RT-PCR products for each amplicon from RNA extracted from whole thoraces, whole heads, and scraped
brain material, and resolved on a 2% agarose gel. Asterisks indicate unexpected products/potentially novel isoforms.
Pound signs label primer dimers.

Figure 12. Brain shows high expression of exon 23 containing isoforms (A) Schematic illustrates target exons for
RT-QPCR primers on mbl RNA transcript. Green dashing represents the location of the amplified sequence. (B)
Quantitative RT-PCR results for expression of target exon transcripts in the central nervous system tissue when
compared to whole head tissue. Brain shows four-fold expression of exon 23 compared to exons 10, 15 and 20. (C)
Predicted nuclear localization sequence (NLS) of Mbl isoforms, blue line illustrates the position of the NLS. Exons
15 and 20 have high predicted NLS confidence scores. Blue lines indicate position of the nuclear localization
sequence. Nuclear localization sequence prediction scores were taken from https://nls-mapper.iab.keio.ac.jp/cgibin/NLS_Mapper_form.cgi prediction tool.

Figure 13. FISH staining revels localized cluster of exon 23 expression in brain neural tissue. (A) Low
magnification grey scale image of head cross section stained with DAPI. Boxes represent areas of the eye and head
shown at greater magnification in panel B (B) F.I.S.H probe staining targeting mbl alternatively spliced exon
regions. Exon 23 shows strong localized expression in brain tissue. (C) Table illustrating results of F.I.S.H staining
for the presents of mbl transcript alternatively spliced exons: 10, 15, 20 and 23 in specialized adult drosophila tissue.
Exon 15 is expression in all tissue that have Mbl presents. Neural tissue of brain, ventral cord and photoreceptors
show expression of all exons.

Figure 14. Functional assay of flight ability and embryonic lethality for Mbl genetically modified crosses. (A)
Overexpression of mbl in muscles of W1118 pharate adult drosophila using Mef2-Gal4 UAS genetic driver. Mbl
overexpression flies show a 2% to 16% increase in embryonic lethality. (B) 1-day old adult Drosophila with mbl
muscle overexpression using Mef2-Gal4 UAS drivers. Surviving flies display inability to fly in all mbl isoforms
overexpression genotypes except GFP fluorescently labeled isoform C cross. (C) Genetic Knockdown (KD) of mbl
in muscles of W1118 pharate adults using Mef2-Gal4 UAS driver and central nervous system using Elav-Gal4 UAS
genetic driver. Mbl KD in muscles shows 90% embryonic lethality while KD in central nervous system does not
affect embryonic lethality when compared to control.

DISCUSSION:
The place of Drosophila Mbl in the muscleblind protein family
Muscleblind is a founding member of a family of conservative proteins found in a wide range of
taxa, from nematodes to humans [Uniprot database. Family UniProtKB 2022.
https://www.uniprot.org/uniprot]. The common feature of Muscleblind-like proteins is the
presence of Zn-finger domains and multiple isoforms. For example, a close human ortholog
muscleblind-like (MBNL) was described to have 4 isoforms (A, B, C and Ds) isoforms that share
the same N-terminal sequence [Begemann et al, 1997]. Similarly, the muscleblind-like protein in
C.elegans (CeMBL) has two isoforms, a and b, that have the common N-terminus with Zn-finger
domains [Wang et al, 2008].
The C-terminus of the isoforms varies widely, however. Unlike the N-terminus, the C-terminus
is translated into a protein region that can be altered by post-translational modifications such as
phosphorylation which changes the binding of proteins to organelles or other proteins [Austin et
al, 2007]. Another proposed function of the C-terminus is to act as a transcriptional co-repressor
for DNA and RNA binding proteins along with the zinc finger domains [Chinnadurai, 2007]. Ctermini are also suspected to house intrinsically disordered regions, which are peptide sequences
that can be phosphorylated after translation. These dynamic regions influence the protein’s
features such as localization and migration by blocking or allowing proteins to enter the
secretory pathway and regulating extracellular movement. Because of the high variability of Cterminus, their universal functional role is still being debated in the literature.
Longer tails for assembly and nuclear domains
Variability in nuclear localization of Mbl isoforms has been cited in other literature [FernandezCosta et al, 2010], with Mbl A and C showing purely nuclear localization and Mbl B being
localized to both the nucleus and cytoplasm. Furthermore, isoforms showed preferential
localization to certain subcellular compartments. While the 2 CCCH Zfn motifs at the 5’ prime
end of mbl transcript are highly conserved [Yaun et al, 2007], according to flybase annotation
and other literature sources, some isoforms (Ex: Mbl PH) have 4 Zfn motifs [Pascual et al,
2006], located 100 base pair downstream of two universal Zfn motifs (Fig. 5B), establishing
differences in RNA binding capacity among exons.
Our nuclear localization prediction analysis showed that NLS sequences of mbl transcripts are in
the C-terminus of exon 15 and 20 (Fig. 11C). F.I.S.H probe microscopy and qPCR analysis
showed high expression of mbl exon 23 transcript region in the brain which displayed mainly
cytoplasmic mbl expression (Fig. 13C). Longer C-terminus endings in exon 15 and 20
potentially influences the ability of Mbl isoforms to form nuclear domains.
Mbl Isoform functionality
The largest base pair omissions appear near the 3-prime end of the entire mbl RNA transcripts of
some isoforms. There are several isoforms (RP, RD, RN, RO, RU, RA, and RB) which omit
exons 20 and others which omit exon 23 (RH, RJ, RK, RM, RR, RS and RT) which are
approximately 3 and 5 kbps respectively (Fig. 11A). Previous attempts to characterize the
function of cassette exons in MBNL transcripts have shown deletions of specific exons resulting
in changes in protein RNA binding affinity and localization [Tran, et al 2010]. Other studies
show the two zinc finger domains of human MBNL are both located near the N-terminal [Park et
al, 2017] more findings suggest that mbl isoforms also have a similar structure, with the zinc

finger domain being located on exon 2,3 and 5 which appear in all isoforms and not on the
cassette exons [Irion, 2012]. However, studies have also indicated that mbl isoforms show
differences in effectiveness when rescuing mbl KD mutants [Du et al, 2010] hinting that these
longer 3’ terminal exons do have some functional impact on an isoform’s ability to bind to RNA
and regulate splicing.
Thoracic muscles are known for their functional variability and diversity as well as differences in
protein expression [Johnston et al, 2020].
The role of intrinsically disordered regions in protein regulation
Traditionally, proteins were thought to have a linear relationship with their mRNA transcript and
post-translational function. After a protein’s peptide sequence had been coded, its structure was
thought to be static, with the mRNA encoding for the protein’s peptide sequence which then
determines its binding targets and functionality [Anfinsen et al, 1973]. More recently,
advancements in molecular biology and proteomics, have discovered intrinsically disordered
regions (IDR) in proteins, which are domains of a peptide sequence that can be altered posttranslationally, after the pre-mRNA alternative splicing has occurred [Collins et al,
2008]. Proteins that undergo post translational modifications can interact with multiple proteins
and binding sites, their binding affinity can be changed making them more energetically
efficient, and they can even act as scaffolds for numerous other proteins, due to their flexibility
in confirmation [Venkatakrishnan et al, 2014]. Ultimately IDRs enhance protein diversity and
cellular complexity, playing some role in tissue diversification by expanding a proteins role and
consequential, the form and function cells can undertake. [Burgers et al, 2016]. The C-terminal
end of a transcript can be translated into intrinsically disordered domains which can be
phosphorylated causing post translational modifications, suggesting proteins with different Cterminals have differences in their dynamic molecular confirmation [Hejjaoui et al, 2012]. We
have shown that the mbl transcript has multiple C-terminal endings (Fig. 5A), implying Mbl
isoforms could have vast differences in their functional and structural flexibility as well as the
diversity of proteins they can regulate. PTM can change a protein, membrane binding, tissue
specificity, migration, and localization in cellular organelles [Roey et al, 2014]. If certain
isoforms could alter these properties while others do not, this could explain why some exons are
more ubiquitous than others.
Mbl Tissue Diversity
Drosophila muscle blind is documented as a splicing regulator in muscle tissue and central
nervous system [Vicente-Crespo et al, 2008] however there is limited knowledge of Mbl
expression and its splicing regulatory role in other types of tissue. It is accepted that Mbl
expression is common in the photoreceptors of the eyes and muscles, hence the term
“muscleblind”. Analysis of Mbl knockdown mutants in previous studies have revealed Mbl is
integral in splicing regulation of structural muscle proteins. Mbl Knockdowns displayed mis
regulation of alpha actin splicing [Vicente et al, 2007], further study indicated that MblC plays a
strong role in regulation of Troponin T splicing of cardiac muscle, with mutants having
misplaced troponin transcripts and rough eye phenotype [Vicente et al, 2008]. Interestingly our
polyclonal anti-Mbl serum showed low expression of Mbl in muscles besides the subalar and
DFM. Mbl could potentially be more important for correct splicing in some thoracic muscles
than others, as evidence has shown that thoracic muscles do possess molecular diversity,
showing differences in base pair lengths for WupA and TpnC4 [Bryantsev et al, 2019]. Mbl may

have preferential binding to pre-mRNA transcripts of certain structural muscle protein exon
regions that are more prominent in small tubular muscles. F.I.S.H analysis confirmed clear
differential expression, with TDT muscles representing no exonic regions and visceral muscles
of the abdominal lining only displaying exon 15. Head and leg muscles do have clear Mbl
expression. Further analysis with exon specific probes would have to be conducted to confirm
whether these muscles groups also have limited Mbl exon diversity, like straited and visceral
muscles.
Myotonic dystrophy disease models have confirmed neuronal Mbl expression. Modulation of
CUG and CTG expansive repeats on the 3’ UTR of DMPK gene (Dystrophia Myotonia Protein
Kinase) can sequester or rescue Mbl protein to create an effective disease model [Sicot et al,
2011]. These models have reported co-localization of Mbl with untranslated CUG nuclear foci in
neural cells, along with rough eye phenotype [Llmausi et al, 2012], however, neuronal
expression of Mbl in disease model studies is not well investigated, as most studies are primarily
concerned with the effect of Mbl sequestration on muscle protein transcripts. Our F.I.S.H
analysis has revealed that Mbl could be more instrumental in splicing regulation of protein
transcripts in nervous cells than previously thought. All three nervous system tissues; brain, eyes
and ventral cord, have representation of all alternatively spliced exonic region of Mbl that we
investigated (Fig. 13A). This comprehensive exonic expression coupled with the cytoplasmic
Mbl expression observed in the brain and eyes, suggests that Mbl potentially plays multiple
unexplored roles in central nervous system. Despite the expansive expression of Mbl in neuronal
cells, Knockdown of Mbl using the Elav-Gal4 driver did not have any significant lethality when
compared to knockdown using Mef2-Gal4 driver, though Elav Mbl knockdowns might have
other mutant phenotypes that have not been unveiled. The negative outcome of the mbl
knockdown in neurons could be due to inefficiency of the Elav-Gal4 driver.
Moreover, strong expression of Mbl in the gut epithelium’s enterocytes and the testis of the
gonad, which do not have the contractile or motor neural function of muscle and neural cells,
indicate Mbl is a transcriptional regulator for a much more diverse array of proteins than
originally expected. These unanticipated findings add to the complexity of Mbl’s role as a
transcriptional regulator.
Future directions:
Going forward our lab is interested in connecting functional roles of variations in exon splicing.
Many of the previous studies done on Mbl isoform functionality only include 3 to 4 isoforms.
Furthermore, we would like to characterize functionality of mbl in unexpected regions of
expression such as visceral muscles and gonads by knocking down specific isoforms or
eliminating exon regions and studying phenotypical effects on Drosophila.
We also propose F.I.S.H analysis to examine smaller isoforms Mbl PA, Mbl PB, Mbl PY, Mbl
PW and Mbl PZ, lacking in exon 15, 20 and 23. Localization of these isoforms with 3’ prime
exon deletions will confirm the role C-terminus regions in nuclear localization and their ability to
interact with Mbl “M bodies”.

Integration
This research investigates an area of science which entails molecular biology, physiology,
proteomics, and cellular biology. Results were obtained by using methods and literature from the
fields of bioinformatics, molecular diagnostics, genetics, evolution, and cellular biology.
Drosophila was used as a model organism. However, the protein of interest is highly conserved
in humans and has implications in myotonic dystrophy, making our findings potentially
impactful in the medical field as well.
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